Summary
1 | N 6 -METHYLADENOSINE
STUDIES PRIOR TO NEXT GENERATION SEQUENCING
More than 100 posttranscriptional chemical modifications are present on RNA from all kingdoms of life. Most of these modifications are found on ribosomal RNA (rRNA) and transfer RNA (tRNA), which modulate their structures and functions, and hence translation, as they are accessory molecules in these processes. 1 Messenger RNA (mRNA), which is primarily an information-bearing molecule, is also posttranscriptionally modified albeit with fewer types of modifications compared with other RNA species. 1 Early studies on mRNA modifications revealed that N A. [5] [6] [7] Further studies in the 1970s to 1980s detected m 6 A in the RNA of human cancer cell lines, mouse white blood cells, bovine mRNA, mosquito cells, and in a variety of viruses that replicate in the nucleus such as herpes simplex virus type 1 (HSV-1), Rous sarcoma virus (RSV), simian virus 40 (SV40), B77 avian sarcoma virus, and feline leukemia virus. 3, 4, These early studies showed that viral transcripts contain m 6 A levels similar to cellular RNA. Two studies mapped a cluster of 7 m 6 A bases on the src-and env-coding regions of RSV RNA at the single nucleotide level and revealed that each site was heterogeneously methylated, indicating different stoichiometries for each m 6 A site. These results suggested potential host-pathogen interactions that converge on viral RNA. 9, 18 It was also revealed that in cells infected by adenovirus, viral nuclear pre-mRNA had a higher level of m 6 A than viral cytoplasmic mRNA (2.5 vs 1.5 m 6 A bases/transcript), hinting that either m 6 A located in intronic regions is lost during splicing or m 6 A methylation of mRNA is a dynamic process. 6, 7 Since these early studies did not map m 6 A at the transcriptome-wide level, and no knowledge of the methyltransferases, demethylases, or m 6 A-binding proteins was available, the functions of m 6 A remained elusive for decades. Nevertheless, results of these studies have pointed to potential important roles of m 6 A in the life cycle of RNA and DNA viruses, which will be the focus of the current review.
2 | NEXT GENERATION SEQUENCING UNRAVELS THE m 6 A EPITRANSCRIPTOME
Transcriptome-wide mapping of m 6 A was unavailable until N 6 -methyladenosine-sequencing (m 6 A-seq) was developed by 2 independent groups in 2012. 29, 30 In this technique, total RNA or poly(A)-selected RNA was isolated from cells and fragmented to approximately 100 nucleotides. Then, an m 6 A-specific antibody was used to pull down the fragmented RNA followed by deep sequencing of the immunoprecipitated and input fractions. m 6 A peaks on the transcripts were determined by comparing immunoprecipitated and input reads. Both studies found that m 6 A on cellular mRNA was enriched in the 3′ untranslated region (UTR) and with RRm 6 ACH motifs. As an epitranscriptomic mark, m 6 A was found on orthologous genes in both human and mouse cell lines. 29 Analysis of methylated genes revealed enrichments of pathways related to RNA metabolism, transcriptional regulation, splicing, and developmental pathways. 29, 30 One difference between these two studies was that m 6 A was found to be enriched at the 5′UTR near the transcription start site in the 66 Depletion of WTAP or KIAA1429 in the cell decreases the amount of m 6 A, and RBM15/RBM15B is required for methylation of the long noncoding RNA X inactive specific transcript (XIST). [65] [66] [67] Since the RRACH motif is prevalent throughout the transcriptome, it is still not well understood how specificity for an m 6 A site is achieved in different physiological conditions. Under steady-state conditions, the methyltransferase complex is localized to the nucleus; however,
METTL3 is also present in the cytoplasm of cancer cells and is associated with eIF3 to enhance translation. 70 This demonstrates that the localization of METTL3 could be cell type or cell condition dependent and that it may have other functions in addition to its role as a methyltransferase.
To date, 2 m 6 A "erasers" have been characterized. Fat mass and obesity associated (FTO) and AlkB homolog 5 (ALKBH5) are oxygen-, alpha-ketoglutarate-, and iron-dependent enzymes. 40, 71 Before its function as an "eraser" was known, a single nucleotide polymorphism (SNP) in the first intron of FTO was shown to be strongly correlated with obesity. 72 Since it does not affect the protein coding sequence of FTO, the mechanism behind FTO's effect on obesity remains unknown. 73 Recently, one SNP in the first FTO intron was shown to affect long-range DNA-DNA interactions in the promoter of Iroquois homeobox 3 (IRX3), resulting in the increase of IRX3 expression and an obesity phenotype. 74 FTO deficiency in mouse models and humans A and methylated vs unmethylated isoforms.
Since full-length transcripts are used, site-specific detection of m 6 A is not possible.
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Microarray
A tiling array of RNA/DNA probes of 25 nucleotides complementary to RNA of interest is generated. m 6 A disrupts A-T or A-U base pairing, resulting in weaker hybridization with the probe.
Free from nonspecific interactions of antibodybased methods.
Low sensitivity. Li et al 35 resulted in growth retardation, malformations, metabolic changes, and abnormal neuronal signaling. [75] [76] [77] After its role as a demethylase was elucidated, FTO was shown to affect global alternative splicing 38 and to play a role in adipogenesis by regulating the alternative splicing of RUNX1 translocation partner 1 (RUNX1T1). 78 Recently, it has been reported that FTO prefers demethylation of m 6 Am over m 6 A in vivo, leaving ALKBH5 as the sole m 6 A demethylase. 79 Knockdown of ALKBH5 in HeLa cells accelerated mRNA export from the nucleus, and male ALKBH5-deficient mice were infertile due to aberrant spermatogenesis. 40, 80 In spermatocytes, ALKBH5 is essential for the correct splicing of the 3′UTR of transcripts. 80 ALKBH5 also promotes the maintenance of glioblastoma stem-like cells by upregulating forkhead box M1 (FOXM1) expression. 81 Another study found that ALKBH5 expression was induced during hypoxia, leading to increased Nanog homeobox (NANOG) expression in breast cancer stem cells. 82 Among the "reader" proteins, the YTH N ; YTHDC1 regulates RNA splicing by competitively recruiting serineand arginine-rich splicing factor 3 or 10 (SRSF3 or SRSF10) to mRNA and mediates nuclear export by interacting with nuclear RNA export factor 1 (NXF1) 39, 85 ; and YTHDC2 affects both translation and degradation of RNA by interacting with the 40-80S subunit and XRN1, respectively. 55, 86 Recently, 2 independent studies screened for additional "reader" proteins and characterized FMR1 as a sequence context-dependent m 6 A reader that promotes translation of methylated transcripts. 87, 88 Interestingly, a class of "antireader" proteins have been discovered where they preferentially bind to GGACU motifs in the absence of m 6 A. 87, 88 Two of these proteins, G3BP stress granule assembly factor 1 (G3BP1) and G3BP stress granule assembly factor 2 (G3BP2), are stress granule proteins that stabilize unmethylated transcripts. 87, 88 To date, numerous studies have revealed a role of m 6 A in viral replication by modulating the levels of "writers," "erasers," and "readers" in cells. As viruses hijack cellular pathways to favor their replication, it is not surprising that these proteins either promote or inhibit viral replication, depending on the virus or infected cell type.
Conversely, it is also possible that the host cells use m 6 A and its associated proteins as an antiviral mechanism to restrict viral replication. 
| Flaviviruses
Two independent groups simultaneously published epitranscriptomic maps of m "reader" and "antireader" proteins. 94 Targeting "writers" and "erasers" with small molecule inhibitors is a potential approach for antiviral therapies. Various studies have shown that 3DAA, an methyltransferase inhibitor, can reduce viral replication 124, 132, 133 ; however, 3DAA also inhibits histone and DNA methylation. 58 A more specific inhibitor of the "writers" is required to eliminate off target effects. Similarly, an inhibitor of the "erasers," meclofenamic acid, could be used to inhibit HCV replication since m 6 
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